Xanthohumol Metabolism and Signature

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a double‐masked, placebo controlled, randomized clinical trial of xanthohumol, which is a constituent of hops (Humulus lupulus). Hops and its constituents have a long history of use for a variety of conditions. However, knowledge is limited regarding the measurable biological markers of human exposure, and the role of xanthohumol metabolism by microorganisms present in the gut. This information is necessary for the development of xanthohumol as a potential therapeutic intervention in conditions such as inflammatory bowel disease.
Epistemonikos ID: d72613c042bb143585189f665d2f399a16e6d9a4
First added on: May 21, 2024